Long-term outcome of high-intensity focused ultrasound in advanced pancreatic cancer

Pancreas

Volumn 40, Issue 7, 2011, Pages 1080-1086

  Sung, Hye Young ^a,b   Jung, Seung Eun ^b   Cho, Se Hyun ^a   Zhou, Kun ^c   Han, Joon Yeol ^a   Han, Sung Tai ^b   Kim, Jin Il ^a   Kim, Jae Kwang ^a   Choi, Jong Young ^a   Yoon, Seung Kew ^a   Yang, Jin Mo ^a   Han, Chi Wha ^b   Lee, Young Sok ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

HIFU; high intensity focused ultrasound; pancreatic cancer; survival

Indexed keywords

ABDOMINAL PAIN; ABLATION THERAPY; ADULT; AGED; ANOREXIA; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTRAST ENHANCEMENT; FEMALE; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; ILEUS; MALE; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PANCREAS CANCER; PRIORITY JOURNAL; SAFETY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; FEMALE; HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; HUMANS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 80052973729     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31821fde24     Document Type: Article

References (24)

1. Greenlee RT, Murray T, Bolden S, et al. Cancer statistics 2000. CA Cancer J Clin. 2000;50:7-33.
2. Batidas JA, Poen JC, Niederhuber JE. Pancreas. In: Abeloff MD, Armitage JO, Lichter AS, eds. Clinical Oncology. 2nd ed. Philadelphia, PA: Churchill-Livingston; 2000:1749-1783.
3. Benzoni E, Rossit L, Cojutti A, et al. Analysis of survival after pancreatic resection for oncological pathologies Chir Ital. 2007;59:17-25.
4. Goggins M. Molecular markers of early pancreatic cancer. J Clin Oncol. 2005;23:4524-4531. (Pubitemid 46196582)
5. Chua YJ, Cunningham D. Adjuvant treatment for resectable pancreatic cancer. J Clin Oncol. 2005;23:4532-4537. (Pubitemid 46196583)
6. Jemal A, Thomas A, Murray T, et al. Cancer statistics, 2002. CA Cancer J Clin. 2002;52:23-47. (Pubitemid 34110469)
7. Huguet F, Girard N, Guerche CS, et al. Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: A qualitative systematic review. J Clin Oncol. 2009;27:2269-2277.
8. Chauffert B, Mornex F, Bonnetain F, et al. Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study. Ann Oncol. 2008;19:1592-1599.
9. Sultana A, Tudur SC, Cunningham D, et al. Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy. Br J Cancer. 2007;96:1183-1190. (Pubitemid 46625082)
10. Mukherjee S, Hudson E, Reza S, et al. Pancreatic cancer within a UK cancer network with special emphasis on locally advanced non-metastatic pancreatic cancer (LANPC). Clin Oncol (R Coll Radiol). 2008;20:535-540.
11. Jackson A, The Pancreatic Subgroup of ACCORN. Survey of current UK practice of pancreatic cancer management by clinical oncologists. In: Proceedings of Combined Chemo-Radiotherapy for GI Cancer. London: BIR; 2007.
12. Dubinsky TJ, Cuevas C, Dighe MK, et al. High-intensity focused ultrasound: Current potential and oncologic applications. AJR Am J Roentgenol. 2008;190:191-199.
13. Vykhodtseva N, McDannold N, Martin H, et al. Apoptosis in ultrasound-produced threshold lesions in the rabbit brain. Ultrasound Med Biol. 2001;27:111-117. (Pubitemid 32280238)
14. Wu F, Chen WZ, Bai J, et al. Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound. Ultrasound Med Biol. 2001;27:1099-1106. (Pubitemid 32807732)
15. Leslie TA, Kennedy JE. High intensity focused ultrasound in the treatment of abdominal and gynaecological diseases. Int J Hyperthermia. 2007;23:173-182. (Pubitemid 46404254)
16. Wang X, Sun J. High-intensity focused ultrasound in patients with late-stage pancreatic carcinoma. Chin Med J (Engl). 2002;115:1332-1335.
17. Hu Z, Yang XY, Liu Y, et al. Investigation of HIFU-induced anti-tumor immunity in a murine tumor model. J Transl Med. 2007;5:34.
18. Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation: Standardization of terminology and reporting criteria. J Vasc Interv Radiol. 2009;20:377-390.
19. Wu F, Wang ZB, Zhu H, et al. Feasibility of US-guided high-intensity focused ultrasound treatment in patients with advanced pancreatic cancer: Initial experience. Radiology. 2005;236:1034-1040. (Pubitemid 41170870)
20. Zhao H, Yang G, Wang D, et al. Concurrent gemcitabine and high-intensity focused ultrasound therapy in patients with locally advanced pancreatic cancer. Anticancer Drugs. 2010;21(4):447-452.
21. Wang RS, Liu LX, Gu YH, et al. The effect of endostatin and gemcitabine combined with HIFU on the animal xenograft model of human pancreatic cancer. Biomed Pharmacother. 2010;64(5):309-312.
22. Wu F, Wang ZB, Jin CB, et al. Circulating tumor cells in patients with solid malignancy treated by high-intensity focused ultrasound. Ultrasound Med Biol. 2004;30:511-517. (Pubitemid 38581151)
23. Jung SE, Cho SH, Hahn ST, et al. High-intensity focused ultrasound treatment (HIFU) for the advanced pancreatic cancer. J Korean Radiol Soc. 2007;56:555-562.
24. Jung SE, Cho SH, Jang JH, et al. High-intensity focused ultrasound ablation in hepatic and pancreatic cancer: Complications. Abdom Imaging. 2011;36(2):185-195.